Phagos

Phagos
Phagos is developing bacteriophage therapies to combat antibiotic-resistant bacterial infections.
About
What does Phagos do?
Phagos is a biotechnology company focused on developing novel bacteriophage therapies to address the growing threat of antibiotic-resistant bacteria. Their approach leverages the natural predators of bacteria, phages, to create targeted and effective treatments for infections that are no longer responsive to conventional antibiotics.
What is Phagos's revenue?
StartupHub estimates Phagos's annual revenue at $10.9M (range $6.4M to $17.7M, 64% confidence), based on comparable companies in the sector.
What is Phagos's valuation?
StartupHub estimates Phagos's effective valuation at $111.2M (range $71.3M to $171.0M, 19% confidence), based on comparable companies in the sector.
How much funding has Phagos raised?
Phagos has raised a total of $29M in funding. The most recent round on record is Series A.
Where is Phagos headquartered?
Phagos is headquartered in Boston, United States.
When was Phagos founded?
Phagos was founded in 2021.
What industry does Phagos operate in?
Phagos operates in Biotech, MedTech, HealthTech, Drug Discovery, Phage Therapy, Antibiotic Resistance.
How many employees does Phagos have?
Phagos has approximately 74 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
